-
261
Elevated Serum Ceruloplasmin Levels Are Associated with Higher Impulsivity in People with Parkinson’s Disease
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
262
Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus
Published 2025-01-01“…Animal Diseases…”
Get full text
Article -
263
Nomogram for Prediction of Postoperative Delirium after Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease under General Anesthesia
Published 2022-01-01“…Parkinson's Disease…”
Get full text
Article -
264
Sentence Comprehension and Its Association with Executive Functions in Patients with Parkinson's Disease
Published 2011-01-01“…Parkinson's Disease…”
Get full text
Article -
265
Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
266
Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
Published 2014-01-01“…Parkinson's Disease…”
Get full text
Article -
267
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
Published 2024-01-01“…Parkinson's Disease…”
Get full text
Article -
268
Neuronal cell type specific roles for Nprl2 in neurodevelopmental disorder-relevant behaviors
Published 2025-02-01“…Neurobiology of Disease…”
Get full text
Article -
269
Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson’s Disease in Taiwan
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
270
The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project
Published 2011-01-01“…Parkinson's Disease…”
Get full text
Article -
271
Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
272
Behavioral and Emotional Dysfunction in Parkinson’s Disease
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
273
Depression in Parkinson’s Disease: The Contribution from Animal Studies
Published 2017-01-01“…Parkinson's Disease…”
Get full text
Article -
274
S100A9 protein activates microglia and stimulates phagocytosis, resulting in synaptic and neuronal loss
Published 2025-03-01“…Neurobiology of Disease…”
Get full text
Article -
275
Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson’s Disease
Published 2015-01-01“…Parkinson's Disease…”
Get full text
Article -
276
Accuracy of Markerless 3D Motion Capture Evaluation to Differentiate between On/Off Status in Parkinson’s Disease after Deep Brain Stimulation
Published 2018-01-01“…Parkinson's Disease…”
Get full text
Article -
277
Path analysis of farmer knowledge, attitudes, and practices toward lumpy skin disease in beef cattle
Published 2025-02-01“…Animal Diseases…”
Get full text
Article -
278
-
279
Potential Therapeutic Drugs for Parkinson’s Disease Based on Data Mining and Bioinformatics Analysis
Published 2018-01-01“…Parkinson's Disease…”
Get full text
Article -
280
The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
Published 2012-01-01“…Parkinson's Disease…”
Get full text
Article